Task Clinical Trials

Task Clinical Trials TASK is a global clinical research organization dedicated to advancing healthcare through innovative and ethical clinical trials.

We deliver high-quality clinical research solutions that accelerate drug discovery and improve patient outcomes.

Have you been diagnosed with asthma?You may qualify to participate in a clinical research study exploring new ways to ma...
18/06/2026

Have you been diagnosed with asthma?

You may qualify to participate in a clinical research study exploring new ways to manage asthma.

Get in touch with us on WhatsApp at 066 167 3119 or visit:
👉 taskclinical.com/contact-us

All research is approved by SAHPRA and/or a Research Ethics Committee.

Are you taking medication to manage your cholesterol, such as a statin?You may qualify to participate in a clinical rese...
18/06/2026

Are you taking medication to manage your cholesterol, such as a statin?
You may qualify to participate in a clinical research study.

Get in touch with us on WhatsApp at 066 167 3119 or visit:
👉 https://taskclinical.com/studies/

All research is approved by SAHPRA and/or a Research Ethics Committee.

World Blood Donor Day highlights the critical role of voluntary blood donation in healthcare systems and clinical resear...
14/06/2026

World Blood Donor Day highlights the critical role of voluntary blood donation in healthcare systems and clinical research worldwide.

Blood and plasma donation underpin many areas of clinical development, from transfusion medicine to the development of life-saving biologics and therapies.

Clinical research continues to advance:

• Plasma-derived therapies for immune and bleeding disorders

• Improved transfusion safety and compatibility research

• Cell-based therapies requiring donor-derived materials

• Better screening and storage methods to improve global access to safe blood products

Blood donation is one of the most direct ways individuals contribute to saving lives — and it also plays a crucial role in enabling scientific discovery.

At TASK, we recognise the essential link between donors, researchers, and patients in advancing modern medicine.

https://taskclinical.com/

In clinical research, completeness of data is just as important as accuracy. Even small gaps in data collection can affe...
12/06/2026

In clinical research, completeness of data is just as important as accuracy.

Even small gaps in data collection can affect trial outcomes, regulatory decisions, and ultimately patient access to new treatments.

Data completeness ensures that every part of the patient journey is properly captured, including:

• Baseline measurements and eligibility data

• Safety reporting throughout the study lifecycle

• Protocol-defined outcome measures at every visit

• Patient-reported outcomes and quality-of-life data

• Follow-up data, even after treatment completion

Incomplete data can introduce bias, weaken statistical power, and delay study conclusions — even when the rest of the dataset is strong.

As trials become more decentralised and digitally enabled, maintaining completeness across multiple data sources has become both more complex and more critical.

At TASK, we prioritise robust operational processes that ensure data completeness from site to database lock, supporting high-quality, decision-ready results.

https://taskclinical.com/

Rare disease research is one of the most scientifically challenging and innovative areas in clinical trials. Although ea...
09/06/2026

Rare disease research is one of the most scientifically challenging and innovative areas in clinical trials.

Although each rare disease affects a small number of people, there are over 7,000 known rare conditions globally — collectively impacting hundreds of millions of patients.

What is transforming this field:

• Gene therapies targeting root genetic causes of disease

• Small population adaptive trial designs

• Increased use of global patient registries to improve recruitment

• AI-assisted diagnosis helping reduce long diagnostic delays

• Regulatory flexibility supporting faster approval pathways

One of the most important shifts is collaboration — rare disease trials are increasingly global, data-driven, and patient-advocacy led.

At TASK, we support rare disease research that brings hope to patients who have historically had very limited treatment options.

https://taskclinical.com/

One of the most significant shifts in oncology research today is not only how we treat cancer but how early we can detec...
05/06/2026

One of the most significant shifts in oncology research today is not only how we treat cancer but how early we can detect it.

Earlier detection is changing the trajectory of cancer care, moving intervention from late-stage disease management toward prevention and early treatment.

Key advances driving this shift include:

• Liquid biopsies detecting circulating tumour DNA (ctDNA) before symptoms appear

• Improved imaging technologies enabling earlier tumour identification

• Biomarker-driven screening in high-risk populations

• AI-assisted diagnostics identifying subtle patterns in early disease

• Longitudinal monitoring approaches for recurrence detection

Earlier detection does not just improve survival rates — it fundamentally changes what is possible in oncology clinical trials, enabling earlier intervention and more targeted therapies.

At TASK, we support oncology trials that contribute to earlier, more precise, and more effective cancer detection and treatment strategies.

https://taskclinical.com/

World No To***co Day highlights the global impact of to***co use and the critical role research continues to play in imp...
31/05/2026

World No To***co Day highlights the global impact of to***co use and the critical role research continues to play in improving long-term health outcomes.

While smoking rates have declined in many regions, to***co use remains a leading contributor to preventable disease worldwide, linked to respiratory disease, cardiovascular conditions, cancer, and reduced immune health.

Clinical research continues to advance new approaches in:

• Smoking cessation therapies and ni****ne replacement strategies
• Early detection and prevention of smoking-related disease
• Respiratory and cardiovascular treatment innovation
• Understanding the long-term health impact of va**ng and alternative ni****ne products
• Digital health tools that support behavioural change and patient monitoring

One growing area of research is precision smoking cessation, where therapies and interventions are increasingly tailored to individual behavioural, genetic, and metabolic profiles to improve success rates.

As healthcare continues shifting toward prevention and personalised medicine, clinical trials remain essential in shaping more effective approaches to to***co-related disease management and public health.

At TASK, we are proud to support clinical research that contributes to healthier futures and improved patient outcomes worldwide.

https://taskclinical.com/

***coDay

Multiple sclerosis research is entering one of its most promising eras yet. MS is a chronic neurological disease in whic...
30/05/2026

Multiple sclerosis research is entering one of its most promising eras yet.

MS is a chronic neurological disease in which the immune system attacks the protective covering of nerves, disrupting communication between the brain and body. While there is currently no cure, advances in clinical research are rapidly transforming the treatment landscape.

One of the most exciting developments is the growing focus on neuroprotection and remyelination - research aimed not only at slowing disease progression but potentially repairing damaged nerve pathways.

At TASK, we are proud to support neurological and immunological clinical trials that contribute to the future of patient care and scientific advancement.

https://taskclinical.com/

Successful participant recruitment is one of the most important factors in delivering efficient and impactful clinical t...
27/05/2026

Successful participant recruitment is one of the most important factors in delivering efficient and impactful clinical trials.

As protocols become more complex and competition for participants increases, sponsors and research sites are adopting smarter recruitment strategies.

Emerging trends include:

• Digital and social media outreach
• Community-based recruitment initiatives
• Greater focus on participant education
• Decentralised and hybrid trial models
• Improved diversity and inclusion strategies

Strong recruitment not only supports timelines, it also strengthens the quality and representativeness of trial data.

At TASK, participant engagement and recruitment excellence remain central to our approach to clinical research delivery.

https://taskclinical.com/

Immunotherapy remains one of the most exciting and rapidly evolving areas in clinical research. Originally gaining momen...
25/05/2026

Immunotherapy remains one of the most exciting and rapidly evolving areas in clinical research.

Originally gaining momentum in oncology, immunotherapy approaches are now expanding into autoimmune disease, neurology, infectious disease, and chronic inflammatory conditions.

Current trends shaping immunotherapy trials include:

• Bispecific antibodies
• Cell and gene-based immune therapies
• Personalised immunotherapies
• Combination treatment strategies
• AI-assisted immune profiling

As researchers continue to unlock the complexity of the immune system, clinical trials are paving the way for more targeted and effective treatment approaches.

At TASK, we are proud to support innovative immunology and immunotherapy research through high-quality clinical trial ex*****on.

https://taskclinical.com/

Address

Smith Street, Glenlily, Parow
Cape Town
7500

Website

Alerts

Be the first to know and let us send you an email when Task Clinical Trials posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Task Clinical Trials:

Shortcuts

Share

Category